- Home
- CNTX vs LNZA Comparison
CNTX vs LNZA Comparison
Compare CNTX & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- LNZA
- Stock Information
- Founded
- CNTX 2015
- LNZA 2005
- Country
- CNTX United States
- LNZA United States
- Employees
- CNTX N/A
- LNZA N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- LNZA Major Chemicals
- Sector
- CNTX Health Care
- LNZA Industrials
- Exchange
- CNTX Nasdaq
- LNZA Nasdaq
- Market Cap
- CNTX 78.0M
- LNZA 65.7M
- IPO Year
- CNTX 2021
- LNZA N/A
- Fundamental
- Price
- CNTX $0.65
- LNZA $0.28
- Analyst Decision
- CNTX Strong Buy
- LNZA Hold
- Analyst Count
- CNTX 5
- LNZA 2
- Target Price
- CNTX $5.50
- LNZA $2.00
- AVG Volume (30 Days)
- CNTX 330.3K
- LNZA 2.4M
- Earning Date
- CNTX 08-06-2025
- LNZA 08-07-2025
- Dividend Yield
- CNTX N/A
- LNZA N/A
- EPS Growth
- CNTX N/A
- LNZA N/A
- EPS
- CNTX N/A
- LNZA N/A
- Revenue
- CNTX N/A
- LNZA $48,831,000.00
- Revenue This Year
- CNTX N/A
- LNZA $58.17
- Revenue Next Year
- CNTX N/A
- LNZA $10.92
- P/E Ratio
- CNTX N/A
- LNZA N/A
- Revenue Growth
- CNTX N/A
- LNZA N/A
- 52 Week Low
- CNTX $0.49
- LNZA $0.14
- 52 Week High
- CNTX $2.75
- LNZA $2.74
- Technical
- Relative Strength Index (RSI)
- CNTX 51.44
- LNZA 51.07
- Support Level
- CNTX $0.62
- LNZA $0.25
- Resistance Level
- CNTX $0.70
- LNZA $0.33
- Average True Range (ATR)
- CNTX 0.04
- LNZA 0.04
- MACD
- CNTX 0.01
- LNZA -0.00
- Stochastic Oscillator
- CNTX 67.29
- LNZA 37.33
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.